9 results
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
2021 ACR/VF Guidelines ... (GCA) #GiantCell ... #Arteritis #GCA ... ACR2021 #Management #rheumatology ... #algorithm #vasculitis
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... • Giant Cell Arteritis ... arteritis (TAK) ... Sources: GCA ... #algorithm #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Giant Cell Arteritis ... Management Algorithm ... - ACR/VF 2021 Guidelines ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
Clinical Disease Characteristics and Suggested Algorithm for Diagnostic Evaluation of Patients With Symptoms of Polymyalgia Rheumatica

#Diagnosis
Clinical Disease ... and Suggested Algorithm ... #Rheumatology # ... Algorithm #GCA # ... GiantCell #Temporal #Arteritis
Anterior ischemic optic neuropathy (AION) - Recognition of giant cell arteritis (GCA)

1) Is visual loss caused
of giant cell arteritis ... Clinical manifestations ... #Rheumatology # ... Ophthalmology #Diagnosis ... #Algorithm
Takayasu's Arteritis (TAK) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active TAK not on
Takayasu's Arteritis ... Vasculitis Management Algorithm ... - ACR/VF 2021 Guidelines ... TAK #Takayasus #Arteritis ... #algorithm #rheumatology
ANCA-Associated Vasculitis
There are many definitions, but most come down to the presence of granulomas (pathologically or
pathologically or clinically ... polyangiitis (GPA ... #differential #diagnosis ... #algorithm #rheumatology
Evaluation of suspected incomplete Kawasaki Disease

1. AHA consensus recommendations
2. Infants ≤6 months old on day ≥7
if they have no clinical ... purposes of this algorithm ... ≥2.5, coronary arteries ... #Diagnosis #Peds ... Disease #Incomplete #Algorithm
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... median age at diagnosis ... Network (NCCN) guidelines ... importance of clinical ... #algorithm #hematology